Analysts expect Corvus Pharmaceuticals, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 425,766.06 | 528,425.39 | 7.68 M | 7.63 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 350,428.60 | 477,154.87 | 6.88 M | 7.04 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 388,097.33 | 502,790.13 | 7.28 M | 7.33 M |
Analysts expect Corvus Pharmaceuticals, Inc. to report earnings per share of -0.19 for Q3 26, against a range of -0.20 to -0.18. The most recent reported quarter, Q2 26, came in at -0.19, a 18.8% miss against the -0.16 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.60 | -0.18 | -0.13 | -0.10 | -0.12 | -0.15 | -0.15 | -0.19 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.10 | -0.11 | -0.11 | -0.12 | -0.12 | -0.13 | -0.12 | -0.15 | -0.18 | -0.19 | -0.21 | -0.24 | -0.17 | -0.17 | -0.21 | -0.21 | ||||||||||
| Low Estimate | -0.10 | -0.13 | -0.13 | -0.14 | -0.14 | -0.15 | -0.14 | -0.17 | -0.20 | -0.21 | -0.23 | -0.28 | -0.19 | -0.19 | -0.23 | -0.25 | ||||||||||
| Consensus Estimate | -0.10 | -0.12 | -0.12 | -0.13 | -0.13 | -0.14 | -0.13 | -0.16 | -0.19 | -0.20 | -0.22 | -0.26 | -0.18 | -0.18 | -0.22 | -0.23 |
Pull Wall Street consensus for Corvus Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CRVS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CRVS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CRVS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();